Source:http://linkedlifedata.com/resource/pubmed/id/10629546
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2000-2-14
|
pubmed:abstractText |
The inclusion or omission of the alternatively spliced region in the tenascin-C (Tn-C) mRNA gives rise to the large (Tn-C(L)) or small (Tn-C(S)) variant, respectively. Tn-C(L) is thought to be a typical component of provisional extracellular matrices (ECMs) and is expressed during tumour stroma remodelling. Tn-C(L) synthesis has been studied using RNA/RNA in situ hybridization, and Tn-C(L) protein distribution, using immunohistochemistry (clone BC-2), in 18 oral squamous cell carcinomas (OSCCs) of different grades of malignancy. While the Tn-C(L) protein was demonstrated within the whole stromal compartment regardless of grade of malignancy, the majority of the Tn-C(L) mRNA signal-bearing cells were carcinoma cells. Only a few stromal myofibroblasts were able to synthesize Tn-C(L), as revealed by alpha-smooth muscle actin double staining. In well-differentiated carcinomas (G1), the Tn-C(L) synthesizing carcinoma cells were localized as a single positive cell layer in the tumour stroma interface, particularly in invasive areas. A higher grade of malignancy (G2/G3) is associated with a significantly increased number of Tn-C(L) synthesizing carcinoma cells randomly distributed within the invading tumour areas. Double-staining experiments (Tn-C(L) mRNA ISH/BC-2 immunohistochemistry) indicate that these cells are capable of organizing and depositing a three-dimensional Tn-C(L) matrix. Even though an instructive and/or inductive role of the carcinoma cells in tumour stroma formation cannot be excluded, these results demonstrate that carcinoma cells can directly produce the ECM components of tumour stroma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-3417
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1999 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
475-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10629546-Basement Membrane,
pubmed-meshheading:10629546-Carcinoma, Squamous Cell,
pubmed-meshheading:10629546-Humans,
pubmed-meshheading:10629546-Immunohistochemistry,
pubmed-meshheading:10629546-In Situ Hybridization,
pubmed-meshheading:10629546-Mouth Mucosa,
pubmed-meshheading:10629546-Mouth Neoplasms,
pubmed-meshheading:10629546-Neoplasm Proteins,
pubmed-meshheading:10629546-Protein Isoforms,
pubmed-meshheading:10629546-RNA, Neoplasm,
pubmed-meshheading:10629546-Statistics, Nonparametric,
pubmed-meshheading:10629546-Tenascin
|
pubmed:year |
1999
|
pubmed:articleTitle |
Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
|
pubmed:affiliation |
Institute of Pathology, Friedrich Schiller University, Jena, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|